Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Application of mivacurium in day surgery
ChiCTR2200064344Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of mivacurium in None (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Onset and clinical action time of muscle relaxants. Started Oct 2022; status: recruiting.
02
Drugs
mivacurium
Beyond the preview
Go deeper on ChiCTR2200064344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064344.